Related Experiment Videos
Cholangiocytes and blood supply.
Eugenio Gaudio1, Antonio Franchitto, Luigi Pannarale
1Department of Human Anatomy, University of Rome, La Sapienza, Rome, Italy. eugenio.gaudio@uniroma1.it
World Journal of Gastroenterology
|June 15, 2006
Summary
The peribiliary plexus (PBP) supports biliary function and proliferates during bile duct ligation. Vascular Endothelial Growth Factor (VEGF) drives this PBP expansion, suggesting therapeutic potential for liver diseases.
Area of Science:
- Hepatology
- Vascular Biology
- Biliary System Anatomy
Background:
- The peribiliary plexus (PBP) is the microvascular supply of the biliary tree, crucial for bile duct epithelium function.
- Understanding PBP organization in normal and pathological conditions is essential for biliary health.
Purpose of the Study:
- To investigate the three-dimensional structure of the PBP in normal and cholestatic liver models.
- To explore the role of Vascular Endothelial Growth Factor (VEGF) in PBP proliferation during bile duct ligation (BDL).
Main Methods:
- Scanning Electron Microscopy vascular corrosion casts (SEMvcc) technique for PBP visualization.
- Bile duct ligation (BDL) model in rats to induce cholestasis and PBP changes.
- Immunohistochemistry to assess VEGF-A and VEGF-C expression.
- Administration of anti-VEGF antibodies and recombinant VEGF-A to modulate PBP response.
Main Results:
- The normal PBP shows a capillary network around bile ducts, becoming more complex with larger ducts.
- BDL induces significant PBP proliferation, forming a distinct three-dimensional vascular network around bile ducts.
- VEGF-A and VEGF-C are highly expressed in proliferating cholangiocytes during BDL.
- Inhibition of VEGF reduces bile duct mass, while VEGF-A administration promotes cholangiocyte proliferation in BDL rats.
Conclusions:
- Arterial blood supply to the biliary tree, via the PBP, is critical during cholangiocyte proliferation in chronic cholestasis.
- VEGF acts as a signaling molecule between cholangiocytes and PBP endothelial cells.
- Targeting VEGF pathways offers a potential therapeutic strategy for liver diseases involving biliary tree damage.